Navigation Links
Steroid-Free Liver Transplants

A new study out of Belgium suggests children undergoing liver transplants may fare better if they don't receive steroids. //

Ever since organ transplants began, steroids have played a major role in helping recipients fend off rejection of their new organ. However, the treatment is not without side effects, especially in children. Steroids have been linked to infections, high blood pressure, elevated blood cholesterol, and impaired growth in young patients.

Researchers in this study tested the use of a newer anti-rejection drug in a group of 20 children needing liver transplants to see if the new drug might solve some of these problems. The patients received a combination therapy in which the drug basiliximab replaced steroids in an otherwise standard treatment.

The children were all followed for at least a year. Investigators compared outcomes for the group with those from a similar group of 20 children who had received liver transplants in the past and had been given steroid treatment.

The study found children on the newer combination of medications had a 25 percent graft rejection rate after one year vs. 50 percent among those who had received steroid therapy following their transplant. Children on the new treatment also had a reduced need for high blood pressure medications and appeared to begin catching up on growth soon after their transplant. Cholesterol levels at the one-year follow up were about the same in the children who received the new treatment as those seen among kids who received the standard treatment with steroids.

Author Raymond Reding notes, "Our results suggest no harmful effect of steroid avoidance for graft acceptance, but this finding will need to be confirmed after extended follow-up."


'"/>




Page: 1

Related medicine news :

1. Blood Cells Capable of Regenerating Liver
2. Liver donors can thrive after transplant
3. Heavy Drinking Raises Risk of Liver Cancer
4. Arthritis Drug May Cause Liver Damage
5. Liver transplant oversight urged
6. Liver key to extending life
7. Liver cancers which spread are linked to a particular gene
8. Liver diseases: The enemy with an accomplice
9. Troubled Childhood found to affect your Liver
10. New Liver Tumor Treatment
11. Transplants Help Liver Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... ... ... the day, adults often find themselves reaching for a cup of coffee, an energy drink, ... for instead is a cup of Matcha green tea. Matcha is a premium green tea ... harvested from early June to mid-July, when the leaves are the most tender. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... St. ... (Healthconnect) regional health information exchange, which enables physicians at SJMC’s two hospital campuses, ... from other participating organizations in the exchange. SJMC’s membership in the health information ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... DDL, Inc. ... American Association for Laboratory Accreditation (A2LA) to include ISO 594-1 and ISO 594-2 testing ... means of achieving a leak-free connection between two medical devices (e.g. a syringe and ...
(Date:5/31/2016)... ... May 31, 2016 , ... The successful implementation of “lean ... laboratories as well. However, laboratories have different challenges compared to manufacturing environments. , ... in the lab, METTLER TOLEDO has developed the Lean Lab Checklist . This ...
(Date:5/31/2016)... ... May 31, 2016 , ... In his latest ... personality traits in humans. Using presidential candidate Donald Trump as an example, Kalsi ... , “AstroNumerology is not about adding numbers up,” says Kalsi. “It is about ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
Breaking Medicine Technology: